When the Canadian Abortion Rights Action League recently released its report detailing the status of abortion “rights” in Canada, missing from it was an extensive analysis of the situation in British Columbia.

The reason? In the dying days of the NDP regime, the government passed draconian “protection of privacy” legislation that meant that even Canada’s foremost pro-abortion organization could not lift the curtain on the status of when and where abortions are being committed in B.C. Publicly funded hospitals were not even allowed to admit if they were committing abortions.

But beyond that, such secrecy surrounding abortion also means that the public cannot learn important details regarding the tragic death of a Canadian woman participating in Ellen Wiebe’s trial of the French abortion drug, RU-486.

B.C.’s provincial government, which financially participated in the study, will release no information, nor is it willing to even admit it has any details surrounding the death.

In an interesting twist, Health Canada views the results of an investigation they themselves conducted into the death “proprietary information” ultimately owned by the abortionist herself.

LifeSite Daily News was able to confirm B.C. news reports that stated Health Canada’s investigation into the death was complete. Tara Madigan, a spokesperson with Health Canada, told LifeSite that the results were secret, or owned by the “investigator,” – in this case, Ellen Wiebe.

Pro-Lifers are highly doubtful the information will ever see the light of day; that is, if Ellen Wiebe has anything to say about it. Wiebe is B.C.’s foremost abortionist, working almost fanatically to achieve the perfect abortion procedure and increase its availability.

Wiebe’s controversial studies have included everything from the use of herbs to induce abortion, methotrexate abortion (another chemical procedure to abort) and the use of aromatherapy in order to create a stress-free environment for the aborted woman.

The death of the unknown Canadian woman occurred Sept. 1, 2001, and was part of a second study into the effectiveness of the French abortion pill. Health Canada suspended the trials after the death, but Wiebe stated she would apply to have the study continued now that the results of the investigation are complete. “Pro-choice” leaders are insisting that the death was not at all related to the abortion pill.

Campaign Life Coalition British Columbia president John Hof said, “How anyone can suggest that the death of this woman was not associated with the drug is stretching believability. The point is she would not have died if she had not participated in this trial and ingested the two drugs needed to kill her child.”

There have been at least five reported North American deaths associated with the use of RU-486 since November 1997.

Some news reports have suggested that both the U.S.-based Population Council and the Food and Drug Administration participated in the Canadian investigation.

At press time, pro-life groups in the United States were still trying to obtain details of the last reported death in November 2001. RU-486 was okayed by the FDA in the last months of the Clinton presidency.

Over 1,000 Canadian women have participated in the first Canadian clinical trial, with another 1,500 women slated to participate in the second study, according to Wiebe. Health Canada has not made it public about whether it will allow the trials, derailed due to the 2001 death.

The Canadian public, and women considering using RU-486, continue to be in the dark.